Molecular alterations in primary prostate cancer after androgen ablation therapy.
Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH, González S, Velasco A, Linehan WM, Matusik RJ, Price DK, Figg WD, Emmert-Buck MR, Chuaqui RF.
Best CJ, et al. Among authors: duray ph.
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6823-34. doi: 10.1158/1078-0432.CCR-05-0585.
Clin Cancer Res. 2005.
PMID: 16203770
Free PMC article.